Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2019

Open Access 01.12.2019 | Research

Indications for extrahepatic bile duct resection due to perineural invasion in patients with gallbladder cancer

verfasst von: Suguru Maruyama, Hiromichi Kawaida, Naohiro Hosomura, Hidetake Amemiya, Ryo Saito, Hiroki Shimizu, Shinji Furuya, Hidenori Akaike, Yoshihiko Kawaguchi, Makoto Sudo, Shingo Inoue, Hiroshi Kono, Daisuke Ichikawa

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2019

Abstract

Background

The indications for extrahepatic bile duct (EHBD) resection remain a major controversy in the surgical management of patients with gallbladder cancer. On the other hand, perineural invasion (PNI) was reported as an important factor in patients with gallbladder cancer because gallbladder cancer cells frequently spread to the tissues surrounding the EHBD via perineural routes. We assessed the correlation of PNI with clinicopathological factors in patients with gallbladder cancer to elucidate EHBD resection indications specifically in patients with PNI.

Methods

This retrospective study assessed the PNI status of 50 patients with gallbladder cancer who underwent curative resection and examined the correlation between the presence of PNI and clinicopathological factors.

Results

Thirteen patients (26%) were PNI positive. PNI was significantly correlated with male sex, proximal-type tumor, lymphatic and vascular invasion, and advanced T stage. Multivariate analysis found that PNI positivity (p < 0.001), lymphatic invasion (p = 0.007), and nodal stage (p < 0.001) were independent prognostic factors. PNI was never observed in patients with stage T1 cancer. Conversely, PNI was detected rarely in distal-type tumors, all of whom developed various types of recurrences.

Conclusions

These results clearly demonstrated the prognostic impact of PNI in patients with gallbladder cancer. We suggest that EHBD resection in combination with cholecystectomy may not be useful for distal-type tumors from a perspective of PNI.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
EHBD
Extrahepatic bile duct
PNI
Perineural invasion

Introduction

Gallbladder cancer is recognized as one of the most aggressive tumors, with a dismal prognosis [1]; even after curative surgery, the prognosis ranges from 17 to 45% [2]. In addition to aggressive nature of cancer, the anatomic features of the gallbladder such as the absence of a submucosal layer and close proximity to the liver and the hepatoduodenal ligament can encourage progression and spread of the lethal disease [3, 4]. Curative surgical resection (R0) is the only treatment approach that can provide long-term survival, and procedures vary depending on the extent of the tumor spread [5]. Some studies recommend radical cholecystectomy with extrahepatic bile duct (EHBD) resection in patients with gallbladder cancer even in the absence of direct invasion to the hepatoduodenal ligament based on studies showing that gallbladder cancer cells frequently spread to the tissues surrounding the EHBD via perineural and lymphatic routes [6, 7]. In fact, the dense neural network comprising nerve fibers and plexuses circumvolutes EHBD. Furthermore, there is abundant nerve tissue surrounding the gallbladder and the bile duct [8]. Tumor cells can also spread through the perineural space. Importantly, perineural invasion (PNI) was reported as a significant prognostic factor in patients with gallbladder cancer [6, 9].
At our institution, as a principle, we have been performing radical cholecystectomy with EHBD resection in patients with gallbladder cancer except for those patients with mucosal cancer. In the current study, we assessed correlations between PNI and clinicopathological factors in patients with gallbladder cancer who underwent surgical resection with or without EHBD resection and elucidated the indications for EHBD resection with a focus on the clinical significance of PNI.

Methods

Patients

Between 2001 and 2017, 68 patients with gallbladder cancer underwent surgical resection at the University of Yamanashi Hospital. Patients who underwent non-curative resection were excluded from the study. Thus, 50 patients who underwent surgery were included in this retrospective study. We diagnosed all cases as gallbladder cancer using computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS) before surgery; therefore, there was no incidental cancer. None of the patients received preoperative chemotherapy or chemoradiotherapy. In principle, cholecystectomy with EHBD resection was performed in patients with gallbladder cancer except for those patients with mucosal cancer. The clinicopathological features of the cases were reviewed based on data recorded in the hospital database. Tumor specimens and resected lymph nodes were obtained at the time of surgery, fixed immediately in 10% neutral-buffered formalin, and embedded in paraffin. Macroscopic and microscopic classification of gallbladder cancer was based on the Union for International Cancer Control classification, 7th edition. Complications were defined using the Clavien classification, and grade ≥ 2 complications were recorded [10]. Tumors invading the neck or the cystic duct of the gallbladder were defined as proximal-type, and those localized in the body or the fundus were defined as distal-type. Circumferential tumor locations were categorized as hepatic and non-hepatic, and circumferential involvement was recorded as hepatic.
Postoperative follow-up comprised evaluation of hematological parameters, computed tomography, and ultrasonography. Follow-up procedures were performed every 3 months for at least 2 years and subsequently continued periodically for at least 5 years. The study was approved by the Ethics Committee of the Yamanashi University and performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.

Statistical analysis

Comparisons between two groups were made using the Student’s t test. Associations between PNI and categorical variables were evaluated using the χ2 test. Survival curves were constructed using the Kaplan–Meier method and compared using the log-rank test. Multivariate analyses of prognostic factors related to survival were performed using the Cox proportional hazards test. Statistical significance was set at a p < 0.05. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria) [11].

Results

The relationship of PNI with clinicopathological factors in patients with gallbladder cancer

The clinicopathological characteristics of the patients included in the present study are summarized in Table 1. PNI adjacent to the tumor lesion was detected in 13 of the 50 cases (26.0%). Representative photomicrographic images of PNI are shown in Fig. 1. PNI was correlated significantly with male sex (p = 0.021), presence of postoperative chemotherapy (p < 0.001), presence of postoperative complications (p = 0.049), proximal-type tumor (p = 0.003), lymphatic invasion (p = 0.003), vascular invasion (p < 0.001), and advanced T stage (p = 0.010). PNI was not detected in patients with stage T1 cancer. PNI did not correlate with other clinicopathological factors such as N stage, numbers of resected lymph nodes, and lymph node ratio (Table 2).
Table 1
Clinicopathological characteristics of the 50 gallbladder cancer patients
Characteristics
Number of patients (%)
Age (years)
 < 70
23 (46.0)
 70 ≦
27 (54.0)
Gender
 Male
17 (34.0)
 Female
33 (66.0)
Size (mm)
 <35
26 (52.0)
 35≦
24 (48.0)
Circumferential tumor location
 Hepatic side
32 (64.0)
 No hepatic side
18 (36.0)
Tumor location
 Proximal
20 (40.0)
 Distal
30 (60.0)
Surgical approach
 EHBD resection (-)
19 (38.0)
 EHBD resection (+)
31 (62.0)
Postoperative complications
 No
46 (92.0)
 Yes
4 (8.0)
Postoperative chemotherapy
 No
31 (62.0)
 Yes
19 (38.0)
Liver resection
 No
20 (40.0)
 Yes
30 (60.0)
T category
 T1
14 (28.0)
 T2
29 (58.0)
 T3
7 (14.0)
N category
 N (-)
37 (74.0)
 N (+)
13 (26.0)
Perineural invasion
 No
37 (74.0)
 Yes
13 (26.0)
EHBD extrahepatic bile duct
Table 2
Relationships between perineural invasion and clinicopathologic factors of gallbladder cancer patients
Characteristics
PNI (−)
PNI (+)
p value
 
n = 37 (74.0%)
n = 13 (26.0%)
 
Age (years)
 < 70
15 (40.5)
8 (61.5)
0.215
 70 ≦
22 (59.5)
5 (38.5)
 
Gender
 Male
9 (23.4)
8 (61.5)
0.021*
 Female
28 (75.7)
5 (38.5)
 
Postoperative chemotherapy
 No
29 (78.4)
2 (15.4)
< 0.001*
 Yes
8 (21.6)
11 (84.6)
 
Postoperative complications
 No
36 (97.3)
10 (76.9)
0.049*
 Yes
1 (2.7)
3 (23.1)
 
Size (mm)
 < 35
20 (54.1)
6 (46.2)
0.751
 35 ≦
17 (45.9)
7 (53.8)
 
Circumferential tumor location
 Hepatic side
21 (56.8)
11 (84.6)
0.098
 No hepatic side
16 (43.2)
2 (15.4)
 
Tumor location
 Proximal
10 (27.0)
10 (76.9)
0.003*
 Distal
27 (73.0)
3 (23.1)
 
Lymphatic invasion
 No
27 (73.0)
3 (23.1)
0.003*
 Yes
10 (27.0)
10 (76.9)
 
Vascular invasion
 No
32 (86.5)
3 (23.1)
< 0.001*
 Yes
5 (13.5)
10 (76.9)
 
T category
 T1
14 (37.8)
0 (0.0)
0.010*
 T2, T3
23 (62.2)
13 (100.0)
 
N category
 N (-)
29 (78.4)
8 (61.5)
0.281
 N (+)
8 (21.6)
5 (38.5)
 
Number of resected lymph nodes
6.32
5.00
0.494
Lymph node ratio
0.24
0.21
0.791
PNI perineural invasion. Significant differences between samples are indicated as *p <0.05

The prognostic impact of HH

The median follow-up period of the study cohort was 63 months. Figure 2 shows the survival curves stratified according to the PNI status. Briefly, the overall and disease-free survival rates were significantly lower in the PNI-positive patients compared with the PNI-negative patients (p < 0.005 and p < 0.001, respectively).
Univariate analysis identified lymphatic and vascular invasion as well as the N stage as significant prognostic factors, whereas age, sex, tumor size, tumor location, EHBD resection, and the T stage were not found to be significantly associated with prognosis (Table 3). Subsequent multivariate analysis demonstrated that the presence of PNI was an independent prognostic factor (p < 0.001), as were lymphatic invasion (p = 0.007) and N stage (p < 0.001) (Table 3).
Table 3
Univariate and multivariate disease-free survival analyses of prognostic factors
 
Univariate
 
Multivariate
 
Characteristics
p value
Hazard ratio
95% CI
p value
Age years
 < 65
0.410
  
NA
 65 ≦
    
Gender
    
 Male
0.114
  
NA
 Female
    
Size (mm)
    
 < 35
0.433
  
NA
 35 ≦
    
Circumferential tumor location
    
 Hepatic side
0.073
  
NA
 No hepatic side
    
Tumor location
    
 Proximal
0.500
  
NA
 Distal
    
EHBD resection
    
 No
0.352
  
NA
 Yes
    
Liver resection
    
 No
0.706
  
NA
 Yes
    
Lymphatic invasion
    
 No
0.056
  
NA
 Yes
    
Vascular invasion
    
 No
0.018*
1
  
 Yes
 
1.465
0.201–3.015
0.717
T category
    
 T1
0.177
   
 T2, T3
   
NA
N category
    
 N (-)
< 0.001*
1
  
 N (+)
 
13.24
3.759–46.64
< 0.001*
Perineural invasion
    
 No
< 0.001*
1
  
 Yes
 
11.96
2.594–55.14
< 0.001*
EHBD, extrahepatic bile duct; CI, confidence interval; NA, not adopted. Significant differences between samples are indicated as *p <0.05
In this series, PNI was found in only three of the 30 cases with distal-type gallbladder cancer; all three patients were treated by cholecystectomy with EHBD resection. However, all patients developed various types of recurrences even after R0 resection; therefore, the extended procedures were found not to have clinical therapeutic efficacy in these patients.

Discussion

Malignant tumors develop and progress via various routes of spread including hematogenous and lymphatic dissemination and local invasion. Local invasion is generally divided into direct invasion with destruction of the existing tissues and tumor spread through the loose space with particular histologic nature. As a representative of the latter, spreading through perineural space, i.e., PNI, is widely recognized as an important adverse pathological feature of many malignancies including pancreatic, prostate, and neck cancers [12, 13]. In these cancer types, the presence of PNI is a well-known poor prognostic factor [12, 13]. Similarly, PNI is detected frequently in gallbladder cancer and acknowledged for its clinical significance [6, 9].
PNI was detected more frequently in hepatic-sided and proximal-type gallbladder cancer in the current study cohort. Furthermore, PNI was an independent prognostic factor. However, our analysis indicated that PNI was not correlated with lymph node metastasis although lymphatic vessels and lymph nodes are adjacent to the nerves and plexuses around the gallbladder and the EHBD. Results from several recent experimental studies suggested that tumor cells might have increased affinity for nerve [14], implicating PNI in arising from a reciprocal interaction between the tumor cells and the microenvironment of the host nerve. The mechanisms of progression through nerve fibers and the lymphatic route might be distinct. To support this possibility, there was no significant correlation between PNI and specific recurrence patterns such as lymphatic or local recurrence in the current study cohort (data not shown).
Whether EHBD resection should be routinely performed in patients with gallbladder cancer remains controversial [5]. Some studies suggested that EHBD resection should be performed routinely during radical cholecystectomy [6, 15, 16], whereas others reported that EHBD resection did not improve prognosis [1719]. D’ Angelica et al. suggested EHBD resection is appropriate when necessary to clear disease but are not mandatory in all cases [20]. We agree with this report. Moreover, they have reported that the median number of lymph nodes was similar regardless of whether EHBD resection had been performed, and lymphadenectomy plus EHBD resection was not associated with an improvement in survival [17, 20]. Therefore, routine EHBD resection was not associated with lymph node yield or survival. Recently, Kurahara et al. found that EHBD resection improved prognosis in patients with proximal-type gallbladder cancer [21].
Considering that EHBD resection in combination with cholecystectomy is recognized as extended wide resection for cases with spread through PNI, EHBD resection is not necessary for patients with stage T1 gallbladder cancer with no evidence of PNI. Conversely, PNI was rarely detected in distal-type gallbladder cancers. The lower frequency of PNI in distal-type tumors might be due to the sparse nerve networks in the distal lesion or might reflect a biological feature. Intraoperative pathological diagnosis for the proximal margin should be useful for the decision for performing EHBD resection. However, PNI cannot be diagnosed before surgery. Therefore, it is important to know that PNI is detected more frequently in proximal-type gallbladder cancer and rarely detected in distal-type cancer.
All patients with PNI-positive distal-type gallbladder cancer developed recurrence despite the EHBD resection. In this study, there were no cases of R1 resection for not performing EHBD; however, two cases with PNI-positive distal-type gallbladder cancer were R1 resection despite performing EHBD resection (data not shown). These results indicate that EHBD resection in combination with cholecystectomy failed to provide prognostic benefit for those with distal-type gallbladder cancer. However, the number of distal-type gallbladder cancer was small in this study, and further studies are warranted to confirm that. If patients with PNI-positive distal-type gallbladder cancer obtain long-term prognosis by performing EHBD resection, EHBD resection should be performed even for patients with distal-type cancer.
To the best of our knowledge, no studies to date evaluated the clinical significance of EHBD resection for gallbladder cancer in the context of PNI. Magnon et al. demonstrated that surgical sympathectomy prevented the early-phase prostate cancer development [22], whereas Zhao et al. demonstrated that surgical denervation of the stomach markedly reduced gastric tumor incidence and progression [23]. Total resection of the nerve tissues around the EHBD should be discussed in two aspects: survival benefit with total removal of the tumor cells around the nerve tissues and potential post-denervation effects on tumor development and progression. The current study demonstrated that EHBD resection in combination with cholecystectomy may not provide any overt survival benefits at least for certain subsets of patients with gallbladder cancer. However, this study has certain limitations. The number of cases analyzed was small, and multi-center large-scale investigations are necessary to confirm these results.

Conclusions

In conclusion, the current study clearly demonstrated the prognostic impact of PNI in patients with gallbladder cancer. We suggest that EHBD resection in combination with cholecystectomy may not be useful at least in patients with stage T1 disease and distal-type tumors from a perspective of PNI.

Acknowledgements

The authors are grateful to Makiko Mishina for expert technical assistance.
The study was approved by the Ethics Committee of the Yamanashi University and performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.
All study participants provided informed written consent prior to their study enrollment.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. The Australian and New Zealand journal of surgery. 1995;65(10):724–7.CrossRef Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. The Australian and New Zealand journal of surgery. 1995;65(10):724–7.CrossRef
2.
Zurück zum Zitat Lim H, Seo DW, Park DH, Lee SS, Lee SK, Kim MH, Hwang S. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. Journal of clinical gastroenterology. 2013;47(5):443–8.CrossRef Lim H, Seo DW, Park DH, Lee SS, Lee SK, Kim MH, Hwang S. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. Journal of clinical gastroenterology. 2013;47(5):443–8.CrossRef
3.
Zurück zum Zitat Shih SP, Schulick RD, Cameron JL, Lillemoe KD, Pitt HA, Choti MA, Campbell KA, Yeo CJ, Talamini MA. Gallbladder cancer: the role of laparoscopy and radical resection. Annals of surgery. 2007;245(6):893–901.CrossRef Shih SP, Schulick RD, Cameron JL, Lillemoe KD, Pitt HA, Choti MA, Campbell KA, Yeo CJ, Talamini MA. Gallbladder cancer: the role of laparoscopy and radical resection. Annals of surgery. 2007;245(6):893–901.CrossRef
4.
Zurück zum Zitat Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW. Current status on cholangiocarcinoma and gallbladder cancer. Liver cancer. 2016;6(1):59–65.CrossRef Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW. Current status on cholangiocarcinoma and gallbladder cancer. Liver cancer. 2016;6(1):59–65.CrossRef
5.
Zurück zum Zitat Hueman MT, Vollmer CM Jr, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16(8):2101–15.CrossRef Hueman MT, Vollmer CM Jr, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16(8):2101–15.CrossRef
6.
Zurück zum Zitat Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Jang KT. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22(8):2779–86.CrossRef Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Jang KT. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22(8):2779–86.CrossRef
7.
Zurück zum Zitat Jung W, Jang JY, Kang MJ, Chang YR, Shin YC, Chang J, Kim SW. Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with T2 gallbladder cancer. Gut Liver. 2016;10(1):140–6.CrossRef Jung W, Jang JY, Kang MJ, Chang YR, Shin YC, Chang J, Kim SW. Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with T2 gallbladder cancer. Gut Liver. 2016;10(1):140–6.CrossRef
8.
Zurück zum Zitat Jensen KJ, Alpini G, Glaser S. Hepatic nervous system and neurobiology of the liver. Comprehensive Physiology. 2013;3(2):655–65.PubMedPubMedCentral Jensen KJ, Alpini G, Glaser S. Hepatic nervous system and neurobiology of the liver. Comprehensive Physiology. 2013;3(2):655–65.PubMedPubMedCentral
9.
Zurück zum Zitat Suzuki S, Yokoi Y, Kurachi K, Inaba K, Ota S, Azuma M, Konno H, Baba S, Nakamura S. Appraisal of surgical treatment for pT2 gallbladder carcinomas. World journal of surgery. 2004;28(2):160–5.CrossRef Suzuki S, Yokoi Y, Kurachi K, Inaba K, Ota S, Azuma M, Konno H, Baba S, Nakamura S. Appraisal of surgical treatment for pT2 gallbladder carcinomas. World journal of surgery. 2004;28(2):160–5.CrossRef
10.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Annals of surgery. 2009;250(2):187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Annals of surgery. 2009;250(2):187–96.CrossRef
11.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone marrow transplantation. 2013;48(3):452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone marrow transplantation. 2013;48(3):452–8.CrossRef
12.
Zurück zum Zitat Soo KC, Carter RL, O'Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. The Laryngoscope. 1986;96(10):1145–8.CrossRef Soo KC, Carter RL, O'Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. The Laryngoscope. 1986;96(10):1145–8.CrossRef
13.
Zurück zum Zitat Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. Journal of surgical oncology. 1997;65(3):164–70.CrossRef Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. Journal of surgical oncology. 1997;65(3):164–70.CrossRef
14.
Zurück zum Zitat Bakst RL, Wong RJ. Mechanisms of perineural invasion. J Neurological Surg Part B Skull Base. 2016;77(2):96–106.CrossRef Bakst RL, Wong RJ. Mechanisms of perineural invasion. J Neurological Surg Part B Skull Base. 2016;77(2):96–106.CrossRef
15.
Zurück zum Zitat Shimizu Y, Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Kato A, Miyazaki M. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136(5):1012–7 discussion 1018.CrossRef Shimizu Y, Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Kato A, Miyazaki M. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136(5):1012–7 discussion 1018.CrossRef
16.
Zurück zum Zitat Pandey D, Garg PK, Manjunath NM, Sharma J. Extra-hepatic bile duct resection: an insight in the management of gallbladder cancer. Journal of gastrointestinal cancer. 2015;46(3):291–6.CrossRef Pandey D, Garg PK, Manjunath NM, Sharma J. Extra-hepatic bile duct resection: an insight in the management of gallbladder cancer. Journal of gastrointestinal cancer. 2015;46(3):291–6.CrossRef
17.
Zurück zum Zitat Kosuge T, Sano K, Shimada K, Yamamoto J, Yamasaki S, Makuuchi M. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? Hepato-gastroenterology. 1999;46(28):2133–7.PubMed Kosuge T, Sano K, Shimada K, Yamamoto J, Yamasaki S, Makuuchi M. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? Hepato-gastroenterology. 1999;46(28):2133–7.PubMed
18.
Zurück zum Zitat Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, Yoshikawa T, Yamamoto M, Takasaki K. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surgery today. 2009;39(9):770–9.CrossRef Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, Yoshikawa T, Yamamoto M, Takasaki K. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surgery today. 2009;39(9):770–9.CrossRef
19.
Zurück zum Zitat Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, Li W, Ma L, Wang L. Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced T stage. PloS one. 2016;11(11):e0166361.CrossRef Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, Li W, Ma L, Wang L. Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced T stage. PloS one. 2016;11(11):e0166361.CrossRef
20.
Zurück zum Zitat D’Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16(4):806–16.CrossRef D’Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16(4):806–16.CrossRef
21.
Zurück zum Zitat Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Mori S, Arigami T, Kijima Y, Shinchi H, et al. Indication of extrahepatic bile duct resection for gallbladder cancer. Langenbeck’s Archives Surg. 2018;403(1):45–51.CrossRef Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Mori S, Arigami T, Kijima Y, Shinchi H, et al. Indication of extrahepatic bile duct resection for gallbladder cancer. Langenbeck’s Archives Surg. 2018;403(1):45–51.CrossRef
22.
Zurück zum Zitat Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science (New York, NY). 2013;341(6142):1236361.CrossRef Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science (New York, NY). 2013;341(6142):1236361.CrossRef
23.
Zurück zum Zitat Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6(250):250ra115.CrossRef Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6(250):250ra115.CrossRef
Metadaten
Titel
Indications for extrahepatic bile duct resection due to perineural invasion in patients with gallbladder cancer
verfasst von
Suguru Maruyama
Hiromichi Kawaida
Naohiro Hosomura
Hidetake Amemiya
Ryo Saito
Hiroki Shimizu
Shinji Furuya
Hidenori Akaike
Yoshihiko Kawaguchi
Makoto Sudo
Shingo Inoue
Hiroshi Kono
Daisuke Ichikawa
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2019
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1735-0

Weitere Artikel der Ausgabe 1/2019

World Journal of Surgical Oncology 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.